PubMed:19891556 / 448-758
Annnotations
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 6780 | 73-80 | GeneOrGeneProduct | denotes | CYP2C19 | NCBIGene:1557 |
| 6781 | 158-169 | ChemicalEntity | denotes | clopidogrel | MESH:D000077144 |
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 0-310 | Sentence | denotes | Several studies have reported that, compared with wild-type individuals, CYP2C19 variant allele carriers exhibit a significantly lower capacity to metabolize clopidogrel into its active metabolite and inhibit platelet activation, and are therefore at significantly higher risk of adverse cardiovascular events. |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 73-80 | GeneOrGeneProduct | denotes | CYP2C19 |
| T6 | 96-104 | GeneOrGeneProduct | denotes | carriers |
| T7 | 179-185 | GeneOrGeneProduct | denotes | active |
| T8 | 218-228 | GeneOrGeneProduct | denotes | activation |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 73-80 | GeneOrGeneProduct | denotes | CYP2C19 |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 73-80 | GeneOrGeneProduct | denotes | CYP2C19 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T10 | 158-169 | ChemicalEntity | denotes | clopidogrel | D000077144|http://purl.obolibrary.org/obo/CHEBI_37941|ChemicalEntity |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T10 | 158-169 | ChemicalEntity | denotes | clopidogrel | ChemicalEntity|http://purl.obolibrary.org/obo/CHEBI_37941|D000077144 |
| T2 | 73-80 | GeneOrGeneProduct | denotes | CYP2C19 |